GeoVax Labs Inc expected to post a loss of 77 cents a share - Earnings Preview

Geovax Labs

25/03/2025 20:02

GeoVax Labs Inc GOVX.OQ GOVX.O is expected to show a rise in quarterly revenue when it reports  results on March 27 for the period ending December 31 2024

The Smyrna Georgia-based  company is expected to report revenue of $2.38 million, according to the mean estimate from 5 analysts, based on LSEG data.

‚ÄčLSEG's mean analyst estimate for GeoVax Labs Inc is for a loss of 77 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč

Wall Street's median 12-month price target for GeoVax Labs Inc is $15.00‚Äč, above‚Äč its last closing price of $1.40. ‚Äč‚Äč‚Äč

Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč

QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-1.43
-1.48
-0.91
Beat
38.4
Jun. 30 2024
-2.51
-3.36
-1.99
Beat
40.9
Mar. 31 2024
-5.56
-5.56
-2.47
Beat
55.6‚Äč
Dec. 31 2023
-2.27
-2.78
-13.60
Missed
-389.8
‚Äč‚ÄčSep. 30 2023
-3.60
-3.60
-4.80
Missed
-33.3
Jun. 30 2023
-2.45
-2.47
-3.30
Missed
-33.3‚Äč
Mar. 31 2023
-3.05
-3.05
-2.25
Beat
26.2
Dec. 31 2022
-3.75
-3.00
-3.00
Met
0

This summary was machine generated March 25 at 20:02 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)